BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7285294)

  • 1. Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate.
    Patterson E; Gibson JK
    Circulation; 1981 Nov; 64(5):1045-50. PubMed ID: 7285294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic ventricular tachyarrhythmias in the conscious dog: prevention by UM-272 (dimethylpropranolol).
    Patterson E; Lucchesi BR
    J Cardiovasc Pharmacol; 1981; 3(4):769-80. PubMed ID: 6167806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.
    Holland K; Patterson E; Lucchesi BR
    Am Heart J; 1983 May; 105(5):711-7. PubMed ID: 6846113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of bretylium to suppress inducible ventricular tachycardia.
    Greene HL; Werner JA; Gross BW; Sears GK
    Am Heart J; 1983 May; 105(5):717-21. PubMed ID: 6846114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
    Kabell G
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic testing of bretylium tosylate in sustained ventricular tachycardia.
    Bauernfeind RA; Hoff JV; Swiryn S; Palileo E; Strasberg B; Scagliotti D; Rosen KM
    Am Heart J; 1983 Jun; 105(6):973-80. PubMed ID: 6858846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion.
    Gibson JK; Stewart JR; Li YP; Lucchesi BR
    J Cardiovasc Pharmacol; 1983; 5(4):517-24. PubMed ID: 6193345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life threatening ventricular dysrhythmias: intervention with bretylium tosylate.
    Sullivan HE; Wehner RJ
    AANA J; 1983 Jun; 51(3):284-9. PubMed ID: 6613506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs.
    Rosalion A; Snow NJ; Horrigan TP; Noon DL; Mostow ND
    Ann Thorac Surg; 1991 Jan; 51(1):81-5. PubMed ID: 1985582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
    Heissenbuttel RH; Bigger JT
    Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bretylium tosylate: a review.
    Bryan CK; Darby MH
    Am J Hosp Pharm; 1979 Sep; 36(9):1189-92. PubMed ID: 386786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bretylium tosylate on the in vivo fibrillating canine ventricle.
    Breznock EM; Kagan K; Hibser NK
    Am J Vet Res; 1977 Jan; 38(1):89-94. PubMed ID: 835872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bretylium tosylate in patients with acute myocardial infarction.
    Torresani J
    Am J Cardiol; 1984 Jul; 54(2):20A-25A. PubMed ID: 6464996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bretylium (Bretylol) for ventricular arrhythmias.
    Med Lett Drugs Ther; 1978 Dec; 20(24):105-6. PubMed ID: 713969
    [No Abstract]   [Full Text] [Related]  

  • 15. Vagally-mediated atrial fibrillation in dogs: conversion with bretylium tosylate.
    Goldberger AL; Pavelec RS
    Int J Cardiol; 1986 Oct; 13(1):47-55. PubMed ID: 3771001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.
    Puddu PE; Jouve R; Saadjian A; Torresani J
    J Pharmacol; 1986; 17(3):223-43. PubMed ID: 3795968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of bretylium tosylate on ventricular arrhythmias in patients with acute myocardial infarction].
    KochmaƄski M; Rdzanek H; Zochowski RJ
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):901-4. PubMed ID: 1341893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of refractory ventricular tachycardia and fibrillation by bretylium tosylate: a report of 4 cases].
    Li SZ; Xu XH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Aug; 15(4):203-4, 12. PubMed ID: 3440418
    [No Abstract]   [Full Text] [Related]  

  • 20. A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium.
    Wenger TL; Lederman S; Starmer CF; Brown T; Strauss HC
    Circulation; 1984 Jan; 69(1):142-8. PubMed ID: 6689638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.